Morgan Stanley’s Alvotech ALVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.47M Buy
670,041
+426,764
+175% +$1.53M ﹤0.01% 4722
2026
Q1
$834K Sell
243,277
-11,947
-5% -$52.5K ﹤0.01% 5241
2025
Q4
$1.31M Buy
255,224
+80,153
+46% +$506K ﹤0.01% 5051
2025
Q3
$1.43M Sell
175,071
-182,224
-51% -$1.55M ﹤0.01% 4970
2025
Q2
$3.26M Sell
357,295
-655,093
-65% -$6.15M ﹤0.01% 4389
2025
Q1
$9.79M Sell
1,012,388
-469,680
-32% -$5.7M ﹤0.01% 3358
2024
Q4
$19.6M Sell
1,482,068
-257,272
-15% -$3.17M ﹤0.01% 2768
2024
Q3
$20.7M Buy
1,739,340
+1,681,049
+2,884% +$19.5M ﹤0.01% 2770
2024
Q2
$709K Sell
58,291
-767,310
-93% -$10.3M ﹤0.01% 5141
2024
Q1
$10.1M Buy
825,601
+825,575
+3,175,288% +$12.1M ﹤0.01% 3342
2023
Q4
$298 Buy
26
+25
+2,500% +$236 ﹤0.01% 7260
2023
Q3
$9 Buy
+1
New +$9 ﹤0.01% 7563
2023
Q2
Sell
-1,193
Closed -$15.4K 7655
2023
Q1
$15.4K Sell
1,193
-1,038,727
-100% -$13.3M ﹤0.01% 6725
2022
Q4
$10.4M Hold
1,039,920
﹤0.01% 3047
2022
Q3
$7.03M Buy
1,039,920
+1,038,128
+57,931% +$8.01M ﹤0.01% 3340
2022
Q2
$15K Buy
+1,792
New +$16.7K ﹤0.01% 7089

Other funds holding ALVO

Morgan Stanley's ALVO Position: Q2 2026 in Review

Morgan Stanley increased its Alvotech (ALVO) stake by 175% in Q2 2026, buying an estimated $1.53M and bringing the position to 670,041 shares worth $2.47M. The position accounts for ﹤0.01% of the portfolio, ranked #4722.

Morgan Stanley first reported a position in ALVO in Q2 2022 and has held it in 16 quarters since. The position peaked at $20.7M in Q3 2024. 72 funds tracked by Wall St. Rank hold ALVO as of Q2 2026.

  • Morgan Stanley held 670,041 shares of Alvotech worth $2.47M as of Q2 2026.
  • Morgan Stanley bought 426,764 Alvotech shares in Q2 2026, an estimated $1.53M.
  • Alvotech made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #4722 holding.
  • Morgan Stanley first reported a position in Alvotech in Q2 2022 and has held it in 16 quarters since.
  • Morgan Stanley's Alvotech position peaked at $20.7M in Q3 2024.
  • 72 funds tracked by Wall St. Rank held Alvotech as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.